Related Experiment Video

Updated: Feb 14, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.8K

Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach

Gary J Noel1, Sumathi Nambiar2, John Bradley3

  • 1Johnson & Johnson, Raritan, New Jersey.

Journal of the Pediatric Infectious Diseases Society
|February 14, 2018
PubMed

Insights

Pediatric antibacterial drug development faces challenges. Addressing five key areas can expedite antibiotic availability for children post-adult approval.

Area of Science:

  • Pediatric Pharmacology
  • Antimicrobial Drug Development
  • Clinical Trial Design

Background:

  • Antibiotic development historically prioritizes adult populations.
  • Limited availability of approved antibiotics for pediatric use.
  • Need for streamlined processes in pediatric antibacterial drug research.

Purpose of the Study:

  • To identify challenges in pediatric antibacterial drug development.
  • To recommend improvements for current practices.
  • To accelerate the availability of novel antibiotics for children.

Main Methods:

  • Convened stakeholders from the pediatric antibacterial drug development community.
  • Focused on identifying key challenges and proposing solutions.
  • Considered five major areas for improvement.

Main Results:

  • Identified critical challenges across the pediatric drug development pipeline.
  • Developed recommendations for enhancing pediatric antibacterial drug research.
  • Highlighted five pivotal areas requiring focused attention.

Conclusions:

  • Addressing identified challenges can significantly improve pediatric antibiotic access.
  • Streamlining development pathways is crucial for timely pediatric drug approval.
  • Collaborative efforts are essential to advance pediatric antibacterial drug availability.

Keywords:
antibacterialantibioticsclinical trialsdrug development

More Related Videos

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.7K
Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.7K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
251
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
316
Critical Region, Critical Values and Significance Level01:16

Critical Region, Critical Values and Significance Level

The critical region, critical value, and significance level are interdependent concepts crucial in hypothesis testing.
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in  probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
13.4K
Critical Values01:31

Critical Values

A critical value is a definite value obtained from a particular probability distribution at a predecided confidence level (or a predecided significance level) for a given population parameter. The critical value provides demarcation that separates the sample statistics that are likely to occur from the ones that are unlikely to occur based on the given probability distribution and the population parameter to be estimated. The critical value for normal distribution is obtained from the z...
10.4K